Takushi Namba Selected Research

Takushi Namba Research Topics

Disease

9	Neoplasms (Cancer) 10/2018 - 03/2007
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 09/2012 - 03/2010
3	Lung Injury 09/2012 - 03/2010
3	Alzheimer Disease (Alzheimer's Disease) 03/2012 - 07/2009
3	Inflammation (Inflammations) 09/2011 - 07/2009
3	Colitis 05/2009 - 08/2007
3	Carcinoma (Carcinomatosis) 02/2009 - 03/2007
2	Obesity 10/2023 - 01/2023
2	Fibrosis (Cirrhosis) 09/2010 - 03/2010
2	Mitochondrial Diseases (Mitochondrial Disease) 05/2007 - 09/2005
1	Body Weight (Weight, Body) 10/2023
1	Insulin Resistance 10/2023
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Pre-Eclampsia (Preeclampsia) 10/2015
1	Adenocarcinoma 04/2015
1	Pulmonary Emphysema 09/2011
1	Chronic Obstructive Pulmonary Disease (COPD) 09/2011
1	Pneumonia (Pneumonitis) 09/2011
1	Emphysema 09/2011
1	Breast Neoplasms (Breast Cancer) 05/2011
1	Neoplasm Metastasis (Metastasis) 05/2011
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2011
1	Infections 11/2010
1	Stomach Ulcer (Gastric Ulcer) 11/2010
1	Idiopathic Pulmonary Fibrosis 03/2010
1	Ulcerative Colitis 01/2009
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2007
1	Hypoxia (Hypoxemia) 03/2007

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2007
4	Bleomycin (Blenoxane)FDA LinkGeneric 09/2012 - 03/2010
4	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 04/2011 - 08/2007
4	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2010 - 08/2007
4	Celecoxib (Celebrex)FDA Link 02/2009 - 09/2005
3	Peptides (Polypeptides)IBA 03/2012 - 07/2009
3	Superoxides (Superoxide)IBA 09/2011 - 01/2009
3	lecithinized superoxide dismutaseIBA 09/2011 - 01/2009
3	Therapeutic UsesIBA 09/2011 - 01/2009
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2010 - 05/2007
2	Endoplasmic Reticulum Chaperone BiPIBA 01/2020 - 10/2018
2	Oxygen (Dioxygen)IBA 09/2012 - 03/2007
2	Amyloid (Amyloid Fibrils)IBA 03/2012 - 04/2011
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 03/2012 - 07/2009
2	geranylgeranylacetone (teprenone)IBA 01/2011 - 09/2010
2	Dextran SulfateIBA 01/2009 - 08/2007
1	Triglycerides (Triacylglycerol)IBA 10/2023
1	malonic acid (malonate)IBA 10/2023
1	AlkaloidsIBA 01/2023
1	pyridoacridineIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Bortezomib (Velcade)FDA Link 01/2020
1	Carbolines (Beta-Carbolines)IBA 10/2018
1	Apoptosis Regulatory ProteinsIBA 08/2018
1	Cyclin-Dependent Kinase Inhibitor p21IBA 08/2018
1	3-aminophenoxazoneIBA 10/2017
1	Sorafenib (BAY 43-9006)FDA Link 10/2017
1	Vardenafil Dihydrochloride (Levitra)FDA Link 10/2015
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 10/2015
1	Protective AgentsIBA 10/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2015
1	avarolIBA 04/2015
1	indium-bleomycinIBA 09/2012
1	Biomarkers (Surrogate Marker)IBA 05/2012
1	Protease Inhibitors (Protease Inhibitor)IBA 09/2011
1	Peptide Hydrolases (Proteases)FDA Link 09/2011
1	SmokeIBA 09/2011
1	Pancreatic Elastase (Elastase)IBA 09/2011
1	AnionsIBA 09/2011
1	Acetaminophen (Paracetamol)FDA LinkGeneric 05/2011
1	Gefitinib (Iressa)FDA Link 01/2011
1	Tyrosine Kinase InhibitorsIBA 01/2011
1	ErbB Receptors (EGF Receptor)IBA 01/2011
1	Indomethacin (Indometacin)FDA LinkGeneric 11/2010
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 09/2010
1	CytokinesIBA 09/2010
1	CollagenIBA 03/2010
1	Hydroxyproline (4 Hydroxyproline)IBA 03/2010
1	Amyloid beta-PeptidesIBA 07/2009
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 07/2009
1	Prostaglandins EIBA 07/2009
1	ProstaglandinsIBA 07/2009
1	Transcription Factors (Transcription Factor)IBA 05/2009
1	CCAAT-Enhancer-Binding ProteinsIBA 05/2009
1	Messenger RNA (mRNA)IBA 05/2009
1	Staphylococcal Protein A (Protein A)IBA 05/2009
1	Interleukin-1beta (Interleukin 1 beta)IBA 05/2009
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2009
1	Cytochromes c (Cytochrome c)IBA 05/2007
1	Small Interfering RNA (siRNA)IBA 05/2007
1	Cysteine Proteases (Cysteine Protease)IBA 09/2005
1	CalpainIBA 09/2005

Therapy/Procedure

2	Therapeutics 10/2015 - 08/2015
2	Intravenous Administration 09/2011 - 01/2009
1	Drug Therapy (Chemotherapy) 05/2011
1	Oral Administration 01/2011